Bill > SB5921

This bill establishes the Washington Medical Psilocybin Act, creating a comprehensive program for the medical use of psilocybin, a naturally occurring psychedelic compound found in certain mushrooms. The bill allows clinicians (licensed healthcare professionals) to prescribe psilocybin to qualified patients who are 18 years or older for medical treatment, with two primary administration models: inpatient medical services (supervised treatment in a clinical setting) and outpatient medical services (self-administered microdosing). The Department of Health will oversee the program, establishing licensing requirements for producers who grow and manufacture psilocybin products, and clinicians who can prescribe them. The bill provides legal protections for participants, ensuring they cannot be arrested or prosecuted for participating in the program, while maintaining strict regulations around product safety, patient care, record-keeping, and professional standards. Notably, the program emphasizes patient safety by requiring detailed training, oversight mechanisms, and clear protocols for treatment. The legislation recognizes psilocybin's potential medical benefits for treatment-resistant conditions and aims to provide safe, controlled access to this emerging medical treatment. The program will take effect on July 1, 2028, giving the state time to develop comprehensive regulations and infrastructure.

Budget and Finance, Health and Social Services

https://app.leg.wa.gov/billsummary?BillNumber=5921&Year=2025&Initiative=false